The company plans to submit efsitora, its once-weekly insulin for type 2 diabetes, to global regulators by end-2026 following ...

Introduction of Twice Daily Glargine Participants randomised to MDI already on twice daily glargine will continue on this from the outset of the RCT.

Sax said the twice-a-year shot might appeal to those who aren't willing or able to take a daily pill. "The key is getting people to take (PrEP) and having them reliably do so," Sax said.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated ...

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

Lantus – said to be the most administered basal insulin across the world – continues to make blockbuster sales, bringing in almost $775 million for Sanofi in the first quarter of this year.

Sax said the twice-a-year shot might appeal to those who aren't willing or able to take a daily pill. "The key is getting people to take (PrEP) and having them reliably do so," Sax said.

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect ...

Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...

WASHINGTON -- The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions -- although it's unclear how many ...